Koen Breyne
- Massachusetts General Hospital · Neurology (investigator's affiliation)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #21,693
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15316490Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-0713-2407Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$813.5K
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#21,693
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Koen Breyne as a PI. Multi-PI records show the full award amount for context.
- 1R37CA302948-01A1R37Contact PIRestoring Dendritic-Cell-Derived Immune Signaling to Reinvigorate T Cells in GlioblastomaMassachusetts General Hospital · Neurology (investigator's affiliation)$652.9Kaward amount
- 5K22CA282019-03K22Contact PIBoosting IL-12-induced anti-glioblastoma activity via immunotherapeutic extracellular vesicles.Massachusetts General Hospital · Neurology (investigator's affiliation)$160.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Koen Breyne as a PI.
FY2026 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding